142 related articles for article (PubMed ID: 15086917)
1. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients.
Passauer J; Lässig G; Büssemaker E; Pistrosch F; Gross P
Kidney Int; 2004 May; 65(5):1782-9. PubMed ID: 15086917
[TBL] [Abstract][Full Text] [Related]
2. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
J Heart Lung Transplant; 2005 Jun; 24(6):665-70. PubMed ID: 15949725
[TBL] [Abstract][Full Text] [Related]
3. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
Ferro CJ; Haynes WG; Hand MF; Webb DJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9.
Passauer J; Pistrosch F; Lässig G; Herbrig K; Büssemaker E; Gross P; Fleming I
Kidney Int; 2005 May; 67(5):1907-12. PubMed ID: 15840038
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine.
Morris ST; McMurray JJ; Rodger RS; Farmer R; Jardine AG
Kidney Int; 2000 Mar; 57(3):1100-6. PubMed ID: 10720962
[TBL] [Abstract][Full Text] [Related]
6. Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients.
Büssemaker E; Herbrig K; Pistrosch F; Palm C; Passauer J
Atherosclerosis; 2009 Dec; 207(2):567-72. PubMed ID: 19717154
[TBL] [Abstract][Full Text] [Related]
7. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P
Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
[TBL] [Abstract][Full Text] [Related]
8. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
Böhm F; Ahlborg G; Pernow J
Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
[TBL] [Abstract][Full Text] [Related]
10. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.
Helmy A; Newby DE; Jalan R; Hayes PC; Webb DJ
Gut; 2003 Mar; 52(3):410-5. PubMed ID: 12584225
[TBL] [Abstract][Full Text] [Related]
11. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X.
Newby DE; Flint LL; Fox KA; Boon NA; Webb DJ
J Am Coll Cardiol; 1998 Jun; 31(7):1585-90. PubMed ID: 9626838
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men.
Westby CM; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA
Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196
[TBL] [Abstract][Full Text] [Related]
13. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
[TBL] [Abstract][Full Text] [Related]
14. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
[TBL] [Abstract][Full Text] [Related]
15. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 and vascular tone in subjects with atherogenic risk factors.
Nohria A; Garrett L; Johnson W; Kinlay S; Ganz P; Creager MA
Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218
[TBL] [Abstract][Full Text] [Related]
17. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
[TBL] [Abstract][Full Text] [Related]
18. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients.
Campia U; Cardillo C; Panza JA
Circulation; 2004 Jun; 109(25):3191-5. PubMed ID: 15148269
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-derived endothelin-1 reduces cerebral artery sensitivity to nitric oxide by a protein kinase C-independent pathway.
Gilbert P; Tremblay J; Thorin E
Stroke; 2001 Oct; 32(10):2351-5. PubMed ID: 11588325
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.
Stauffer BL; Westby CM; Greiner JJ; Van Guilder GP; Desouza CA
Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R261-5. PubMed ID: 19939973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
